Lawrence B. Cohen’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

Lawrence B. Cohen’s Portfolio IRLA Stock Details IRLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-56	Closed	-$12.5K	–	46
2023 Q3	$12.5K	Hold	56	–	–	0.01%	60
2023 Q2	$16.7K	Hold	56	–	–	0.01%	65
2023 Q1	$17.4K	Hold	56	–	–	0.01%	61
2022 Q4	$7.09K	Hold	56	–	–	﹤0.01%	93
2022 Q3	$15K	Hold	56	–	–	0.01%	64
2022 Q2	$25K	Hold	56	–	–	0.02%	62
2022 Q1	$69K	Hold	56	–	–	0.04%	62
2021 Q4	$140K	Hold	56	–	–	0.05%	97
2021 Q3	$1.02M	Buy	56 +11	+24%	+$175K	0.54%	48
2021 Q2	$477K	Hold	45	–	–	0.24%	56
2021 Q1	$324K	Hold	45	–	–	0.18%	64
2020 Q4	$250K	Hold	45	–	–	0.14%	68
2020 Q3	$450K	Hold	45	–	–	0.27%	58
2020 Q2	$417K	Hold	45	–	–	0.28%	55
2020 Q1	$410K	Buy	+45	New	+$444K	0.32%	55

Other funds holding IRLA

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Lawrence B. Cohen's IRLA Position: Q4 2023 in Review

Lawrence B. Cohen sold out of IRulya Therapeutics Inc. Common Stock (IRLA) in Q4 2023, closing a stake of 56 shares — an estimated $12.5K sold.

Lawrence B. Cohen first reported a position in IRLA in Q1 2020 and held it in 15 quarters. The position peaked at $1.02M in Q3 2021. 42 funds tracked by Wall St. Rank hold IRLA as of Q4 2023.

Lawrence B. Cohen reported no remaining IRulya Therapeutics Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Lawrence B. Cohen sold 56 IRulya Therapeutics Inc. Common Stock shares in Q4 2023, an estimated $12.5K.
Lawrence B. Cohen first reported a position in IRulya Therapeutics Inc. Common Stock in Q1 2020 and held it in 15 quarters.
Lawrence B. Cohen's IRulya Therapeutics Inc. Common Stock position peaked at $1.02M in Q3 2021.
42 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q4 2023.

Based on Lawrence B. Cohen's 13F filing for Q4 2023, filed 9 Feb 2024.